Glimepiride Tablet
Product Images NDC 42571-101

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 42571-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glimepride 1mgmicrolabel

Glimepiride Tablets, USP 1 mg oral tablets label showing dosage strength and package size of 100 tablets. The label includes manufacturer information for Micro Labs Limited, Goa, India, and Micro Labs USA Inc., Somerset, NJ. Additional details include dosage administration instructions, storage temperature, and child-resistant container warning. The NDC number 42571-100-01 is displayed along with barcode and revision date 10/2021.*

FDA Label Image

Glimepride 2mgmicrolabel

Label for Glimepiride tablets, USP 2 mg oral tablets by Micro Labs Limited. The label shows NDC 42571-101-01 and indicates a quantity of 100 tablets with dosing instructions of 'once a day.' It includes storage guidelines, a warning to keep out of reach of children, and manufacturer details with locations in India and the USA. A barcode and a DGFT 2D matrix code area are also visible.*

FDA Label Image

Glimepride 3mgmicrolabel

Glimepiride tablets USP 3 mg oral dosage form in a 100-tablet package by Micro Labs Limited. The label includes storage instructions (20°-25°C), a warning to keep out of reach of children, and dispensing guidance. The tablet is indicated for once-a-day use. Manufactured by Micro Labs Limited, India, and for Micro Labs USA, Inc., Somerset, NJ.*

FDA Label Image

Glimepride 4mgmicrolabel

Label for Glimepiride Tablets USP 4 mg, oral tablets. The label states 'Once a day' and contains 100 tablets. Manufactured by Micro Labs Limited, India, and for Micro Labs USA Inc., Somerset, NJ. Dosage and administration refer to package insert. Storage conditions are 20°-25°C. Includes caution to keep out of reach of children and pharmacist dispensing instructions.*

FDA Label Image

Glimepride 6mgmicrolabel

Label for Glimepiride Tablets USP 6 mg oral tablets by Micro Labs Limited. The label states once-a-day dosing with 100 tablets per container. It includes storage instructions, a warning to keep out of reach of children, and mentions the product is manufactured for Micro Labs USA, Inc. The NDC is 42571-104-01.*

FDA Label Image

Glimepride 8mgmicrolabel

Glimepiride tablets, USP 8 mg oral tablets in a package containing 100 tablets. Label includes dosage instructions as once a day and notes the prescription-only status. Manufactured by Micro Labs Limited in Goa, India, and for Micro Labs USA, Inc. in Somerset, NJ. Label also provides storage instructions and child-resistant packaging warning.*

FDA Label Image

Glimepride Strc

Chemical structure diagram of Glimepiride, an active pharmaceutical ingredient shown with detailed molecular connectivity including rings, chains, and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.